393 related articles for article (PubMed ID: 17457360)
1. Technology insight: artificial extracorporeal liver support--how does Prometheus compare with MARS?
Krisper P; Stauber RE
Nat Clin Pract Nephrol; 2007 May; 3(5):267-76. PubMed ID: 17457360
[TBL] [Abstract][Full Text] [Related]
2. Review article: clinical experience with Prometheus.
Rifai K; Manns MP
Ther Apher Dial; 2006 Apr; 10(2):132-7. PubMed ID: 16684214
[TBL] [Abstract][Full Text] [Related]
3. Effect of extracorporeal liver support by molecular adsorbents recirculating system and Prometheus on redox state of albumin in acute-on-chronic liver failure.
Oettl K; Stadlbauer V; Krisper P; Stauber RE
Ther Apher Dial; 2009 Oct; 13(5):431-6. PubMed ID: 19788461
[TBL] [Abstract][Full Text] [Related]
4. Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
Evenepoel P; Laleman W; Wilmer A; Claes K; Kuypers D; Bammens B; Nevens F; Vanrenterghem Y
Artif Organs; 2006 Apr; 30(4):276-84. PubMed ID: 16643386
[TBL] [Abstract][Full Text] [Related]
5. Emerging indications for albumin dialysis.
Sen S; Williams R; Jalan R
Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
[TBL] [Abstract][Full Text] [Related]
6. Removal of bile acids by two different extracorporeal liver support systems in acute-on-chronic liver failure.
Stadlbauer V; Krisper P; Beuers U; Haditsch B; Schneditz D; Jung A; Putz-Bankuti C; Holzer H; Trauner M; Stauber RE
ASAIO J; 2007; 53(2):187-93. PubMed ID: 17413559
[TBL] [Abstract][Full Text] [Related]
7. Albumin regeneration in liver support-comparison of different methods.
Mitzner S; Klammt S; Stange J; Schmidt R
Ther Apher Dial; 2006 Apr; 10(2):108-17. PubMed ID: 16684211
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with Prometheus.
Krisper P; Tiran B; Fliser D; Haditsch B; Stadlbauer V; Otto R; Ernst T; Kretschmer U; Stauber RE; Haller H; Holzer H; Manns MP; Rifai K
Artif Organs; 2010 Jan; 34(1):84-8. PubMed ID: 19663866
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure.
Mitzner SR; Stange J; Klammt S; Peszynski P; Schmidt R; Nöldge-Schomburg G
J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037
[TBL] [Abstract][Full Text] [Related]
10. Clearing of toxic substances: are there differences between the available liver support devices?
Krisper P; Stadlbauer V; Stauber RE
Liver Int; 2011 Sep; 31 Suppl 3():5-8. PubMed ID: 21824275
[TBL] [Abstract][Full Text] [Related]
11. How can liver toxins be removed? Filtration and adsorption with the Prometheus system.
Vienken J; Christmann H
Ther Apher Dial; 2006 Apr; 10(2):125-31. PubMed ID: 16684213
[TBL] [Abstract][Full Text] [Related]
12. Liver support therapy with molecular adsorbents recirculating system in liver failure: a summary of 252 cases from 14 centers in China.
Wang MM; Chen SJ; Ye QF; Yang YJ; Chen SB; Zhou XM; Guo LM; Zhang YX; Ding XQ; Hu XB; Luo HT; Liu YH; Wang WY
Chin Med J (Engl); 2008 Nov; 121(21):2197-201. PubMed ID: 19080184
[TBL] [Abstract][Full Text] [Related]
13. Use of the molecular adsorbent recirculating system (MARS™) for the management of acute poisoning with or without liver failure.
Wittebole X; Hantson P
Clin Toxicol (Phila); 2011 Nov; 49(9):782-93. PubMed ID: 22077243
[TBL] [Abstract][Full Text] [Related]
14. Fractionated plasma separation and adsorption: current practice and future options.
Rifai K
Liver Int; 2011 Sep; 31 Suppl 3():13-5. PubMed ID: 21824277
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus).
Rifai K; Hafer C; Rosenau J; Athmann C; Haller H; Peter Manns M; Fliser D
Scand J Gastroenterol; 2006 Oct; 41(10):1212-7. PubMed ID: 16990208
[TBL] [Abstract][Full Text] [Related]
16. An Australian experience with the molecular adsorbents recirculating system (Mars).
Kurtovic J; Boyle M; Bihari D; Riordan SM
Ther Apher Dial; 2006 Feb; 10(1):2-6. PubMed ID: 16556129
[TBL] [Abstract][Full Text] [Related]
17. Molecular adsorbent recirculating system treatment for patients with liver failure: the Hong Kong experience.
Chiu A; Chan LM; Fan ST
Liver Int; 2006 Aug; 26(6):695-702. PubMed ID: 16842326
[TBL] [Abstract][Full Text] [Related]
18. Modification of continuous venovenous hemodiafiltration with single-pass albumin dialysate allows for removal of serum bilirubin.
Chawla LS; Georgescu F; Abell B; Seneff MG; Kimmel PL
Am J Kidney Dis; 2005 Mar; 45(3):e51-6. PubMed ID: 15754264
[TBL] [Abstract][Full Text] [Related]
19. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.
Laleman W; Wilmer A; Evenepoel P; Elst IV; Zeegers M; Zaman Z; Verslype C; Fevery J; Nevens F
Crit Care; 2006; 10(4):R108. PubMed ID: 16859530
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic improvement as an additional parameter to evaluate the safety and tolerability of the molecular adsorbent recirculating system in liver failure patients.
Pugliese F; Novelli G; Poli L; Levi Sandri GB; Di Folco G; Ferretti S; Morabito V; Ruberto F; Berloco PB
Transplant Proc; 2008; 40(6):1925-8. PubMed ID: 18675091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
